Areas of Research

Epigenetic Regulation of Immune Cell Function in Disease

Nanotherapy Targeting Immune Signaling Pathways and Epigenetic Targets

Next Generation Sequencing

Who We Are

The IECT Labs, led by Dr. Katherine Gallagher, works at the intersection of immunology, biomedical research, and cardiovascular medicine. The fields of immunotherapy and epigenetics have grown tremendously over the previous decade.

Although these areas have been more well studied in cancer, they are relevant for cardiovascular disease and can be specifically targeted using nanocarriers and other technology to modulate inflammation and other pathologic processes in cardiovascular disease and to aid in tissue repair processes.

Our group aims to translate our findings identifying important epigenetic pathways into therapeutic cell specific therapy for the treatment of patients with cardiovascular and cardiometabolic diseases.

11/14/22  Barmada and Gallagher Labs

Latest Publications

Current Status for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association.

Gallagher KA, Mills JL, Armstrong DG, Conte MS, Kirsner RS, Minc SD, Plutzky J, Southerland K, Tomic-Canic M.

Circulation 2024 Jan 23;149(4):e232-e253. 38095068

View Full Publication

circulation

Biofilm-derived oxylipin 10-HOME mediated immune response in women with breast implants.

Bauer TM, Gallagher KA.

J Clin Invest 2024 Feb 1;134(3):e176547. Abstract 38299590

View Full Publication

JCI-insight

Are You a Trainee Looking to Join the Gallagher Lab at U-M?

We are currently looking for new lab members! Master's, doctoral, and post-doctoral students are encouraged to apply.